Menitove J E
Blood Center of Southeastern Wisconsin, Milwaukee 53233.
Annu Rev Med. 1991;42:297-309. doi: 10.1146/annurev.me.42.020191.001501.
Transfusion practice in the 1990s is expected to continue the trend established in the 1980s toward assuring appropriate use of transfusion therapy. Autologous blood collection is expected to increase further, and pharmacologic agents that promote hemostasis or cell production will be integrated into ongoing efforts to reduce homologous blood usage. Although the risk of transfusion-transmitted diseases should continue to decrease, procedures to inactivate viruses in cellular blood components will be evaluated and artificial oxygen-carrying components may become available.
20世纪90年代的输血实践预计将延续20世纪80年代确立的趋势,以确保输血治疗的合理使用。自体血采集预计将进一步增加,促进止血或细胞生成的药物制剂将被纳入正在进行的减少异体血使用的努力中。虽然输血传播疾病的风险应会继续降低,但将对细胞血液成分中病毒灭活程序进行评估,人工携氧成分可能会问世。